Almac Successfully Moves its Clinical Technologies Business Unit Into New North American Headquarters

By Almac Group, PRNE
Tuesday, October 12, 2010

SOUDERTON, Pennsylvania, October 13, 2010 - Almac announced today that its Clinical Technologies division has
successfully moved into the Almac Group's new North American Headquarters.
After groundbreaking of the 40-acre site in Souderton, PA on 23 July 2008,
the drug development firm has now completed the first phase of relocating
employees from three Almac business units to the new 240,000 square feet
state-of-the-art integrated drug development facility.

On 11 October, Almac's technology business unit joined employees from
Almac's analytical testing and clinical supplies units as occupants at the
North American Headquarters. Over the course of the next two months, Almac
will transition the remainder of its clinical supplies operations currently
located in Audubon, PA, into the integrated drug development facility in
Souderton, PA.

The transition of the technologies business into Almac's new North
American Headquarters was carefully planned and executed. Over the course of
the past few months, Almac successfully relocated and tested all of its new
and existing technologies and systems in the new locale to make certain that
there were no disruptions to client studies during the transition into the
North American Headquarters.

Jim Murphy, President of Almac's clinical technologies business unit,
comments on the flawless move of the business from Yardley, PA, to its new
location in Souderton, PA. Murphy: "Our IT, Quality Assurance, senior
management team, and other key personnel worked in unison to ensure that all
of our systems were tested and met the highest standards before we moved into
the new facility. The transition team's meticulous planning enabled us to
avoid any downtime on client studies outside of our normal maintenance
windows. I am delighted to announce that everything went as planned with this
perfectly executed transition."

The move of three Almac business units to a new North American
Headquarters is part of the Almac Group's integrated services solutions
strategy. The new facility was planned to deliver a full-service, integrated
drug supply management and technology solution to biopharmaceutical clients.

Joseph Bedford, Ph.D., Director of Marketing at Almac's Clinical
Technologies business unit comments: "The biopharmaceutical industry is
making great strides to streamline drug development and bring efficiencies to
clinical trials. Our new North American Headquarters allows Almac to deliver
an integrated clinical supplies, analytical testing, and clinical
technologies offering to sponsors that is unparalleled in our industry.
Working with integrated teams of drug supply management and technology
specialists at Almac, our clients will benefit from the combined insights of
experienced professionals who deliver efficiencies in the clinical supplies
chain that no other firm can match."

Almac's Clinical Technologies business unit began work on Monday, October
at the new facility after a celebration on Sunday, during which
employees unpacked their work items and were treated to lunch with families
and friends of Almac. By Monday morning, it was business-as-usual at Almac,
with Clinical Technologies professionals managing hundreds of live studies
for clients.

About Almac Group

The Almac Group comprises of five closely integrated divisions offering a
broad range of services from R&D, biomarker discovery and development, API
manufacture, formulation development, clinical trial supply and IXRS
technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides
services to more than 600 companies, including all the world leaders in the
pharmaceutical and biotech sectors.

The company employs over 2,800 individuals and is headquartered in
Craigavon, Northern Ireland. US operations are based in Pennsylvania, North
and California. Almac has officially gained full possession of its
new $120m North American Headquarters which started in July 2008 and
employees will relocate during the fall.

Almac's Clinical Technologies division specializes in interactive
technology and service solutions to increase the quality and efficiency of
the clinical trial process. Our solutions include Interactive Voice and Web
Response Systems (IXRS(TM)) for patient randomization, tracking and clinical
supply management, electronic-patient-reported-outcomes (ePRO) data
collection, and Web drug reconciliation. Almac's technologies have been
deployed in over 1500 clinical trials, incorporating over 1.5 million
patients in over 80 countries, and more than 60 languages.

For more information about the Almac Group, please visit or e-mail For a virtual tour
of Almac's North American Headquarters, please visit


    Joseph Bedford, PhD
    T: +1-215-660-8500

Contact: Joseph Bedford, PhD, T: +1-215-660-8500, E: clinicaltechnologies at

will not be displayed